β2-Agonists at the olympic games

@article{Fitch20062AgonistsAT,
  title={$\beta$2-Agonists at the olympic games},
  author={Ken D Fitch},
  journal={Clinical Reviews in Allergy \& Immunology},
  year={2006},
  volume={31},
  pages={259-268}
}
  • K. Fitch
  • Published 2006
  • Medicine
  • Clinical Reviews in Allergy & Immunology
The different approaches that the International Olympic Committee (IOC) had adopted to β2-agonists and the implications for athletes are reviewed by a former Olympic team physician who later became a member of the Medical Commission of the IOC (IOC-MC). Steadily increasing knowledge of the effects of inhaled β2-agonists on health, is concerned with the fact that oral β2-agonists may be anabolic, and rapid increased use of inhaled β2-agonists by elite athletes has contributed to the changes to… Expand
Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
TLDR
From 2010 salbutamol and salmeterol are allowed by inhalation requiring a so called declaration of use, as long as a therapeutic use exemption has been applied for and was granted by the relevant anti-doping authorities. Expand
Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008.
TLDR
Asthma management in elite athletes should follow established treatment guidelines and should include education, an individually tailored treatment plan, minimization of aggravating environmental factors, and appropriate drug therapy that must meet the requirements of the World Anti-Doping Agency. Expand
Asthma in elite athletes
TLDR
Elite athletes displaying signs of exercise-induced symptoms, for example, nonasthmatic inspiratory wheeze, vocal cord dysfunction and cardiac arrhythmias, which could limit their physical capacity, should undergo comprehensive assessment to confirm an asthma diagnosis and determine its degree of severity. Expand
The enigma of inhaled salbutamol and sport: unresolved after 45 years.
  • K. Fitch
  • Medicine
  • Drug testing and analysis
  • 2017
TLDR
Concern is expressed at the persistent failure of WADA to apply a correction down to a specific gravity of 1.020 when an exogenous substance is identified in the urine of a dehydrated athlete. Expand
The World Anti-Doping Code: can you have asthma and still be an elite athlete?
TLDR
The World Anti-Doping Code (the Code) does place some restrictions on prescribing inhaled β2-agonists, but these can be overcome without jeopardising the treatment of elite athletes with asthma, a review examines those sections of the Code that are relevant to respiratory physicians who manage elite and sub-elite athlete with asthma. Expand
Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport
  • K. Fitch
  • Medicine
  • Expert review of clinical pharmacology
  • 2010
TLDR
Inhaled glucocorticosteroids and inhaled β2-adrenoceptor agonists (IβA) are the pharmacological agents of choice to manage asthma and minimize EIB, assisted when necessary, by other drugs including leukotriene receptor antagonists and chromones. Expand
Prevalence of bronchoconstriction induced by eucapnic voluntary hyperpnoea in recreationally active individuals
TLDR
Individuals who are recreationally active may benefit from an objective bronchial provocation challenge, given that self-reported symptoms alone only provide a supportive role towards a valid EIB diagnosis. Expand
The breathless adolescent asthmatic athlete
  • K. Carlsen
  • Medicine
  • European Respiratory Journal
  • 2011
TLDR
There are several causes of breathlessness in adolescents, including EIA, vocal cord dysfunction, poor physical fitness and others, which are important to consider in the diagnostic procedure. Expand
Asthma in the Athlete
TLDR
The wide-spread use of asthma drugs among top-athletes has lead the International Olympic Committee, Medical Commission (IOC-MC) and World Anti-Doping Association (WADA) to introduce restriction to the use of Asthma drugs in sports. Expand
Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
TLDR
The results suggest that the inhalation of a single therapeutic dose of terbutaline offers significant protection against hyperpnoea-induced bronchoconstriction and attenuates acute airway epithelial perturbation in athletes. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 39 REFERENCES
Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics.
TLDR
Documentation of airway narrowing in athletes, particularly in response to exercise or surrogate stimuli for exercise, aids in the diagnosis and management of asthma by providing evidence of bronchial hyperresponsiveness that will respond to treatment with inhaled corticosteroids and is usually associated with a reduction in respiratory symptoms on exercise. Expand
Impact of changes in the IOC-MC asthma criteria: a British perspective
TLDR
Screening for asthma within elite athletic populations using bronchoprovocation challenges appears warranted to assist athletes in preparing more effectively for major sporting events. Expand
Influence of a beta2-agonist on physical performance at low temperature in elite athletes.
TLDR
It is concluded that inhalation of a beta2-agonist (terbutaline) in a dose that yields significant bronchodilatation does not influence physical performance at low temperature in healthy athletes. Expand
Management of allergic Olympic athletes.
  • K. Fitch
  • Medicine
  • The Journal of allergy and clinical immunology
  • 1984
TLDR
It is strongly recommended that the Medical Commission of the International Olympic Committee meet with an appropriate body of experts (i.e., the American Academy of Allergy and Immunology) to review this ban on vasoconstrictor agents. Expand
Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.
TLDR
It is demonstrated that it is feasible to request objective evidence to justify use of beta2-agonists on the medical grounds of asthma or EIA. Expand
Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
TLDR
Lung function increased significantly after inhaled formoterol, and after exercise also for placebo, but without differences between the beta2-agonist and placebo after exercise, and in conclusion, inhaledformoterol did not improve endurance performance compared to placebo. Expand
Salbutamol and treadmill performance in non-atopic athletes.
TLDR
The results indicate that therapeutic administration of a selective beta-2 agonist does not affect pulmonary function or performance-related variables in non-atopic elite athletes. Expand
Doping Test Reveals High Concentrations of Salbutamol in a Swiss Track and Field Athlete
TLDR
It is proposed that sanctioning bodies in sport should consider this possibility before taking into account a two-year ban for the use of an anabolic steroid on the basis of the level of salbutamol in urine. Expand
Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men.
TLDR
Oral salbutamol appears to be an effective ergogenic aid in nonasthmatic individuals not experiencing adverse side effects under the conditions of this study. Expand
The effect of salbutamol on performance in elite nonasthmatic athletes.
TLDR
It was concluded that a therapeutic dose of aerosol salbutamol does not have an ergogenic effect in elite nonasthmatic athletes, and it is therefore recommended that inhaled sal butamol continue to be permitted in international competition for individuals with exercise induced bronchospasm. Expand
...
1
2
3
4
...